[HTML][HTML] Commercialized blood-, urinary-and tissue-based biomarker tests for prostate cancer diagnosis and prognosis
WCH Visser, H de Jong, WJG Melchers, PFA Mulders… - Cancers, 2020 - mdpi.com
Simple Summary In prostate cancer diagnosis and prognosis, clinicians often must take
decisions on which prostate cancer-suspected patients should undergo biopsy and which …
decisions on which prostate cancer-suspected patients should undergo biopsy and which …
Association of baseline prostate-specific antigen level with long-term diagnosis of clinically significant prostate cancer among patients aged 55 to 60 years: a …
Importance The use of prostate-specific antigen (PSA) screening for prostate cancer is
controversial because of the risk of overdiagnosis and overtreatment of indolent cancers …
controversial because of the risk of overdiagnosis and overtreatment of indolent cancers …
[HTML][HTML] Preoperative prostate health index predicts adverse pathology and Gleason score upgrading after radical prostatectomy for prostate cancer
V Novak, S Vesely, H Luksanová, R Prusa, O Capoun… - BMC urology, 2020 - Springer
Background We aimed to explore the utility of prostate specific antigen (PSA) isoform [− 2]
proPSA and its derivatives for prediction of pathological outcome after radical prostatectomy …
proPSA and its derivatives for prediction of pathological outcome after radical prostatectomy …
[HTML][HTML] Preoperative prostate health index and% p2PSA as the significant biomarkers of postoperative pathological outcomes of prostate cancer in Korean males: A …
H Park, SW Lee, G Song, TW Kang… - … and clinical urology, 2020 - ncbi.nlm.nih.gov
Purpose To evaluate the clinical utility of percentage of serum prostate-specific antigen
(proPSA) to free PSA (% p2PSA) and the prostate health index (PHI) for predicting …
(proPSA) to free PSA (% p2PSA) and the prostate health index (PHI) for predicting …
[HTML][HTML] Explication of the roles of prostate health index (PHI) and urokinase plasminogen activator (uPA) as diagnostic and predictor tools for prostate cancer in …
Abstract Background Prostate cancer (PCa) is one of the most commonly encountered
cancers and the leading cause of death worldwide. Currently used biomarkers accounts …
cancers and the leading cause of death worldwide. Currently used biomarkers accounts …
[HTML][HTML] Preoperative% p2PSA and prostate health index predict pathological outcomes in patients with prostate cancer undergoing radical prostatectomy
YT Cheng, CY Huang, CH Chen, ST Chiu, JH Hong… - Scientific Reports, 2020 - nature.com
To evaluate the predictive accuracy of the% p2PSA and prostate health index (PHI) in
predicting aggressive pathological outcomes in patients with prostate cancer (PCa) …
predicting aggressive pathological outcomes in patients with prostate cancer (PCa) …
[HTML][HTML] 前列腺特异性抗原同源异构体2 及其衍生指标在预测前列腺癌病理分级中的价值
孙奎霞， 闫存玲， 李志艳， 刘平， 张伟… - Journal of Peking …, 2020 - ncbi.nlm.nih.gov
前列腺特异性抗原同源异构体2及其衍生指标在预测前列腺癌病理分级中的价值- PMC Back to Top
Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …
Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …
[PDF][PDF] Subclassification of pathologically organ-confined (pT2) prostate cancer does not significantly predict postoperative outcomes in Korean males
SG Kang, JS Shim, F Onol, KRS Bhat… - … and clinical urology, 2020 - synapse.koreamed.org
Robotic radical prostatectomy (RARP) is a standardized treatment for localized prostate
cancer, which provides better functional outcomes and similar oncological outcomes …
cancer, which provides better functional outcomes and similar oncological outcomes …
[Clinical value of serum isoform [-2] proprostate-specific antigen and its derivatives in predicting aggressive prostate cancer].
KX Sun, CL Yan, ZY Li, P Liu, W Zhang… - … da xue xue bao. Yi xue …, 2020 - europepmc.org
OBJECTIVE: To explore the clinical value of serum isoform [-2] proprostate-specific antigen
(p2PSA) and its derivatives% p2PSA and prostate health index (PHI) in predicting …
(p2PSA) and its derivatives% p2PSA and prostate health index (PHI) in predicting …
Comparison among different precursor prostate-specific antigen isoform derivatives on prostate cancer prediction in patients with serum prostate-specific antigen …
M Stojadinovic, D Pantic, M Andjelkovic, M Stojadinovic - 2020 - scidar.kg.ac.rs
© 2020, Serbia Medical Society. All rights reserved. Introduction/Objective The precursor
prostate-specific antigen (proPSA) especially its isoform p2PSA is useful in the detection of …
prostate-specific antigen (proPSA) especially its isoform p2PSA is useful in the detection of …